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Abstract
Background: Despite being the gold standard of research to determine effectiveness, randomised controlled trials
(RCTs) often struggle with participant recruitment, engagement and retention. These issues may be exacerbated
when recruiting vulnerable populations, such as participants with mental health issues. We aimed to update
understanding of the scope of these problems in trials of health technology and identify possible solutions through
reflecting on experiences from an exemplar trial (Online Remote Behavioural Intervention for Tics; ORBIT).
Method: We extracted anonymised data on recruitment, retention and requests for more funding and time from
trials funded by the largest funder of health technology trials in the UK (the National Institute of Health Research
Health Technology Assessment) between 2010 and 2020, and compared these with data from a recent, successful
trial (ORBIT). ORBIT aimed to assess the clinical- and cost-effectiveness of blended online and human behavioural
therapy for tics in young people. Many of the trial procedures, including recruitment, the intervention and data
collection, were undertaken online.
Results: Data were extracted on 51 trials conducted between 2010 and 2020. Sixty per cent of trials failed to reach
their original recruitment target and only 44% achieved their follow-up in the specified time frame. In contrast,
ORBIT recruited to target and achieved 90% follow-up. We posit that these achievements are related to (a) judicious
use of digital technology for trial procedures and (b) adequate numbers of highly trained and motivated trial staff.
We provide details of both these to help other research teams plan and cost for successful trials.
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Conclusion: An approach combining human and online methods may be advantageous in facilitating trial delivery,
particularly in paediatric mental health services. Given the importance of successful clinical trials in advancing
healthcare delivery and the waste of human and economic resources associated with unsuccessfully delivered trials,
it is imperative that trials are appropriately costed and future research focusses on improving trial design and
delivery.
Trial registration: The ORBIT trial is registered with ISRTCN (ISRCTN70758207) Registered on March 20, 2018. and
ClinicalTrials.gov (NCT03483493). Registered on March 30, 2018.
Keywords: Randomised controlled trials, Internet, Online, Chronic tic disorder, Tourette syndrome, Recruitment,
Retention, Research design
Background
Randomised controlled trials (RCTs) are considered the
‘gold standard’ in research design for determining causal-
ity and assessing clinical- and cost-effectiveness of new
health technologies or practices [1]. Evidence from high-
quality (i.e. considered to be at low risk of bias) trials
forms the basis for many clinical guidelines governing the
delivery of care to patients (e.g., Scottish Intercollegiate
Guidelines Network [2]) and is considered essential by or-
ganisations worldwide charged with determining which
healthcare technologies should be funded such as the Na-
tional Institute of Health and Care Excellence [3] in the
UK and the Agency for Healthcare Research and Quality
(AHRQ) in America [4]. However, RCTs require substan-
tial resources and are often complex to design and deliver,
as well as being demanding on both participants and re-
search staff [5]. Thus, despite being considered the gold
standard, these trials are prone to failure [6, 7], resulting
in wasted resources, on both a time and economic level
and raising ethical queries regarding the involvement of
participants to no scientific advancement [8].
In recognition of the difficulties associated with con-
ducting RCTs, research has examined factors associated
with successful and unsuccessful trial delivery. One of
the most pivotal studies conducted by Campbell et al.
[9] was ‘STEPS’ (strategies for trial enrolment and par-
ticipation study). Focussing on the issue of participant
recruitment, the STEPS team found that less than one
third of trials met their original recruitment target in
time, and one third required a study extension. The
study concluded that it was difficult to determine which
factors were causally related to successful recruitment
but noted that a good communication strategy, a dedi-
cated trial manager and having interventions only avail-
able inside the trial were important factors. Trials which
were deemed as ‘successful’ overall were conducted by
well-regarded investigators and asked clinically import-
ant questions which were grounded in existing clinical
practices. To date, the STEPS study still represents argu-
ably the most comprehensive overview of challenges in
trial recruitment.
Since then, there have been several attempts to define
successful strategies for recruitment [5, 10] however, the
majority have not been formally evaluated [11] or of lim-
ited success/lacking implementation [12]. Indeed, recent
research confirms that recruitment remains a barrier to
successful trial completion, with one paper showing that
only just over half (56%) of trials met their recruitment
target with or without a study extension [13].
Although receiving less attention in the literature, par-
ticipant retention is also considered another significant
threat to the success and validity of RCTs [14]. Whilst
average retention in trials has been estimated at 89%
[13], which may suggest that retention is less of a con-
cern than recruitment, this figure is likely inflated by tri-
als with only short-term follow-ups. Retention has also
been shown to be particularly challenging in certain clin-
ical groups or types of intervention, such as behavioural
intervention trials involving participants with a mental
health disorder [15]. Studies on smoking cessation for
participants with depression or substance use disorders,
for example, have reported follow-up rates as low as 27–
33% [16, 17]. Though underlying factors behind poor re-
tention are difficult to measure, participants report fa-
tigue at completing lengthy assessments, or outcome
measures that do not seem relevant to their condition or
lived experience [18]. Poor retention has substantial im-
plications to a trial, including, increasing study costs by
requiring a larger sample size to achieve adequate power,
and creating bias in results caused by attrition [19], par-
ticularly if there is a differential drop-out rate between
group allocation which cannot fully be accounted for
using statistical methods (such as multiple imputation)
[15]. As such, researchers have also examined factors
that influence good retention and found good communi-
cation which is adapted to suit the individual participant
as well as regular reminders from trial staff to be benefi-
cial [20].
Whilst clinical trials have been traditionally conducted
in a clinical face-to-face setting, since the late 1990s,
there has been an increasing trend towards online or
digital trials [21], in which either the intervention and/or
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the outcome measures are collected remotely. Although
the number of trials investigating an online intervention
has increased over time, the number of online interven-
tions is proportionately low to the number of trials being
conducted, with mental health studies being one of the
most prevalent fields [22]. Online delivery of trials is in-
tuitively attractive, offering the ability for participants to
self-refer, standardise the delivery of interventions, and
allow participants a time-and-location convenient option
to complete outcome measures [14, 23, 24].
There is mixed evidence regarding issues of recruit-
ment and engagement with online trials. Whereas some
trials have reported particularly good recruitment and
engagement (e.g. [25]), other evidence indicates that on-
line trials may be particularly susceptible to poor recruit-
ment, limited engagement with the intervention [26] and
higher drop-out rates [27, 28]. A recent systematic re-
view indicated that trials of web-based interventions
often fail to appropriately account for the level of inter-
vention use (i.e. sessions completed) [22], indicating that
the general acceptability of online interventions is not
yet fully known. Some known possible barriers to the de-
livery of online trials include poor technology skills, in-
terfaces that are not user-friendly, concerns around data
security and a lack of support from healthcare profes-
sionals [26, 29].
An ongoing trial investigating the online delivery of
behavioural therapy for tics (ORBIT trial, [30, 31])
has been particularly effective in recruiting and
retaining participants. Consideration of methodo-
logical and design factors that may have contributed
to this success may offer a helpful learning opportun-
ity for future trials. The trial is a parallel-group,
single-blind RCT which included an internal pilot
phase and was funded by the NIHR Health Technol-
ogy Assessment (HTA) (Ref 16/19/02) and ethically
approved by North West Greater Manchester Re-
search Ethics Committee (Ref 18/NW/0079). The trial
recruited children and young people (aged 9–17 years)
with a tic disorder. Participants were randomised to
receive either an online, therapist supported behav-
ioural intervention for tics or psychoeducation around
tics. The trial used a ‘blended’ approach to delivery,
combining a mix of online (web-based) procedures
and procedures that were delivered, or supported by,
trial therapists and staff (either face-to-face or via vid-
eoconferencing). The trial achieved the aims of the
internal pilot which were set within the first 9 months
of recruitment, with clear stop/go criteria to deter-
mine progression to a full definitive trial. The ORBIT
trial continued to finish recruitment to time-and-
target, maintaining follow-up rates at the primary end
point that exceeded the 80% target, indicating poten-
tial benefits of interventions with online delivery.
This article aims to highlight some of the key risks in
trial delivery and outline some of the trial management
and conduct process that we believe were pivotal to the
ORBIT trial success in achieving recruitment and reten-
tion targets. These learned experiences may help re-
search teams inform their design of future trials, with
specific focus on how online delivery may overcome
some common pitfalls in trial delivery.
Methods
Design
Case study, comparing data from one specific trial
(ORBIT trial, [30]) with RCTs funded by the same
funder (the largest funder of health technology trials in
England) over a 10-year period.
Setting
The National Institute of Health Research (NIHR) is
Europe’s largest funder of health and care research. In
2017–2018 its total budget was over £1billion; £252 mil-
lion was allocated to individual research projects, of
which £78.1 million was disbursed through the Health
Technology Assessment Programme (HTA), responsible
for funding evaluations of new health technologies, in-
cluding pharmacological and non-pharmacological inter-
ventions [32]. As the funder of our case study, and the
largest funder of health technology assessment studies in
England, we deemed this the most suitable source to
identify comparator trials.
Search strategy for comparator trials
We limited our search to the most recent decade (2010–
2020), to allow for learning from the influential STEPS
study [9]. The following inclusion criteria were devel-
oped to ensure we identified all appropriate comparator
studies: (1) recruited participants with a mental health/
behavioural condition, as classified by ICD-10 [33]; (2)
used a RCT design (feasibility and pilot RCTs were in-
cluded); (3) reported a psychological or behavioural
intervention (diagnostic interventions or changes to the
care system were also included); and (4) the trial was
classified by the HTA as completed. Only completed tri-
als were included to reduce data skew from trials still in
the recruitment phase but yet to achieve their specified
targets. Trials classified as CTIMP (Clinical Trial of an
Investigation Medicinal Product) were excluded as it is
possible that recruitment and retention to a drug vs be-
havioural/psychological intervention trial may involve
differential barriers and strategies.
A member of the HTA staff identified all studies
funded between January 2010 to January 2020 which
were coded as ‘mental health’ and/or ‘neurological’. Two
members (CLH, CM) of the ORBIT study team inde-
pendently reviewed the study titles and summaries
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against the inclusion and exclusion criteria. Any dis-
agreements were resolved via discussion until consensus
was reached. Data from the final list of included studies
was provided anonymously by the HTA, with no refer-
ence to potential identifying information such as start/
end dates or condition.
Data extraction
Data on recruitment, retention to follow-up, and re-
quests for variations to contract (either more time to
complete the study, more financial resource or both)
were extracted from anonymised progress and per-
formance reports submitted to the funder by the
Principal Investigators of included trials. Timely sub-
mission of such reports is a requirement of the
funder, and release of funds is dependent on receipt
of these reports. It was not possible to extract infor-
mation about whether trials were conducted online or
not as this is not an HTA reporting requirement, and
as reports were anonymised, we could not cross-
check them with published protocols. The HTA also
do not record engagement with the intervention as a
reportable criteria. However, in light of the recent
systematic review indicating the need for greater un-
derstanding and reporting of engagement with online
interventions [22], we have specifically outlined the
ORBIT processes that we consider may have pro-
moted engagement and treatment completion, al-
though it is not possible to contrast this with other
HTA trials.
Data analysis
Each trial was coded as to whether it met recruitment
and follow-up rates within the specified time frame or
whether a variation to contract (i.e. study extension) was
requested and granted. The primary reason for request-
ing a variation to contract was also coded. Descriptive
statistics (number and percentage of trials) are presented
for each criterion.
We then draw comparisons to the case study, ORBIT,
highlighting key trial design and management processes
that may have been influential in achieving the key tar-
gets. These key processes and reflections were generated
via a focus group consisting of 14 key members of the
ORBIT team management group. This management
group included representatives from trial researchers,
trial therapists, the clinical trials unit, the trial manager,
principal investigators, international collaborators in
Sweden and the chief investigator. The discussion was
led by the trial manager who had generated initial topics
for discussions based on the influential STEPS [9] paper.
Reflections were recorded via typed minutes and
reviewed and approved by the team for accuracy.
Results
One hundred and seventy six studies funded by the
HTA between 2010 and 2020 were classified as ‘mental
health’ or ‘neurological’. Fifty one of these met the inclu-
sion criteria.
Recruitment
Of the 51 studies identified, one had no specified re-
cruitment target. Attainment of recruitment targets for
the remaining 50 studies are presented in Table 1 and
shows that only 20 (40%) studies met their original re-
cruitment target in time, one of which finished recruit-
ment 3months ahead of schedule. Twenty-three (46%)
studies were given a revised target which was achieved
in 61% of cases. Reasons for not meeting the target were
not generally specified, although in one study, it was
noted there was a 6-month delay in initially starting re-
cruitment; however, after a 10-month extension, the
study still did not meet the target.
Seven studies that did not meet the initial target were
not given a revised target for various reasons including:
not feasible to continue (n = 2), reason not clearly speci-
fied (n = 2), safety issues (n = 1), better attrition rate
than anticipated (i.e. still sufficient power) (n = 1), con-
tributing to international study which met overall target
(n = 1), conclusions could be drawn from existing sam-
ple (n = 1).
Retention to follow-up
For the purpose of this paper, ‘follow-up’ refers to
achieving the pre-specified target for participant reten-
tion to the primary outcome at the primary end point.
From the 51 HTA studies, follow-up data was only avail-
able from 34 studies (67%). This missing data was due to
historical limitations with the HTA recording systems.
Table 2 presents the number of trials that met their pre-
specified retention follow-up targets and shows that only
15 (44%) met their initial target. Revised time periods for
data collection were given to three studies, resulting in
one additional study meeting its target (47% of the 34
studies). Reasons for not meeting follow-up targets were
not specified.
Table 1 Number of studies meeting recruitment targets (n =
50)
Met initial target (n = 50) Met revised target (n = 23)
Yes 20 (40%) 14 (61%)
No 30 (60%) 9 (39%)
One study had no specified recruitment target and thus not included in
the table
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Requests for more time, more funds or both (variations to
contract)
Table 3 displays the number of formal requests for varia-
tions to funding contracts. Variations to contracts typic-
ally involved requests for additional funds, time or both
in order to complete the trial. The most common reason
(found in 54% of trials) for requesting a variation to con-
tract was due to issues with participant recruitment. The
length of extensions requested due to issues with re-
cruitment ranged from 2 to 22 months.
Notably, 5 out of the 51 studies requested a variation
to contract due to issues relating to staff (see Table 3).
This was responsible for 13.5% of variation to contract
requests. Out of these 5, a further breakdown of the rea-
sons showed that 2 cited the volume of work (1 specific-
ally linked to recruitment), 1 maternity leave, 1
maternity leave and combined issues with recruitment
and 1 had no further details. Issues with staffing is not a
reportable criterion for HTA studies unless the trial
team are requesting a variation to contract. Thus, it is
not possible to understand the full extent of trials that
are reporting difficulties due to staff/workload which is
impacting on trial delivery.
ORBIT case study
A summary of the ORBIT study flow is presented in
Fig. 1. Recruitment and retention targets and attainment
are shown in Table 4. To determine progression to a full
trial, the first 9 months of the trial included an internal
pilot with key targets. Table 4 shows the attainment of
targets for both the internal pilot and full trial. The re-
quired study sample was 220 participants which was
powered to detect a clinically important average differ-
ence of 0.5 standard deviation between intervention and
comparator with 90% power at p < 0.05 (two-sided), after
allowing for 20% drop-out [30].
Recruitment to ORBIT encompassed three modes of
recruitment: online self-referral, clinical research sites
and participant identification centres. ORBIT followed-
up participants at 3 months post-randomisation (primary
end point, just after completion of the intervention), and
then again at 6, 12 and 18 months post-randomisation.
Follow-ups comprised online self-report measures col-
lected via an online database developed by the Karo-
linska Institutet eHealth Core Facility with automated
and researcher controlled functions and a video-
conference interview with the study researcher. A brief
overview is shown in Fig. 2.
The ORBIT trial met the internal pilot recruitment
targets ahead of schedule and overall recruitment finish-
ing to time and target. The trial exceeded both its in-
ternal pilot target and final follow-up target at the
primary end point (3 months). At the time of publica-
tion, longer-term follow-ups were still ongoing.
Potential reasons for recruiting to target
We considered that the following factors were pivotal to
successful recruitment:
1) National recruitment: Provision of mental health
services is not evenly distributed; thus, there may
be greater uptake of an intervention in under-
provided geographical areas. Furthermore, some
National Health Service (NHS) Trusts are well
established in supporting research; in ORBIT, refer-
rals from Patient Identification Centres (PICs)
ranged from 0 to 27. The PICs were identified ei-
ther via existing connections held by the study team
Table 2 Number of studies meeting follow-up targets (n = 34)
Met initial target (n = 34) Met revised target (n = 3)
Yes 15 (44%) 1 (33%)
No 19 (56%) 2 (67%)
In one case, the follow-up was underestimated from the start but the study
was allowed to continue without a revised target. This has been categorised
as ‘not meeting initial target’
Table 3 Number of studies (n = 51) requesting at least one variation of contract (additional funds, time or both) by reason/issue





Funds Duration Funds and duration Other Requests
Recruitment issues 1 9 10 0 N = 20
Requesting funds =11
11/11
Retention/follow-up issues 1 2 1 0 N = 4
Requesting funds = 2
2/2
Staff issues/volume of work 1 0 4 0 N = 5*
Requesting funds = 5
3/5
Other/not clearly specified 2 1 2 3 N = 8
Requesting funds = 4
4/4
Seven studies requested more than 1 variation to contract
*Two of the 5 staff issues were linked to issues with recruitment
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or via the UK Clinical Research Network (CRN)
database which lists active NIHR funded research
for interested sites to contact the name investigator.
Given the sites were not involved in the delivery of
the intervention and thus were viewed as low-
involvement sites by the study team, no feasibility
checks were conducted. By having a large recruit-
ment area, particularly for disorders with a lower
prevalence rate, the trial was less affected by the
underperformance from an individual region or trial
site.
2) Self-referrals: The majority of ORBIT participants
self-referred online, via a national charity ‘Tourettes
Action’ and the study webpage hosted by the Insti-
tute of Mental Health, University of Nottingham.
Allowing self-referrals enabled participants who
were not currently under the care of a mental
health service to be included. Self-referrals were
particularly useful in the early stages of recruitment
when NHS sites were slow in embedding the identi-
fication process in their workload and there were
frequent hold-ups in gaining local regulatory ap-
provals across the PICs.
3) Unmet need for trial intervention: ORBIT or similar
online interventions were not freely available
outside the trial for the UK. Furthermore, access to
standard face-to-face behavioural therapy for tics is
scarce with only 1 in 5 people having access to
evidence-based treatment [34]. Conversely, there
may be pragmatic barriers to recruiting participants
Fig. 1 ORBIT study flow. DAWBA, Development And Well-Being Assessment given at screening to determine eligibility; PIC, patient
identification centre





66 participants by 9th month 67 participants by 6th month
Full trial 220 by 18th month 224 by 18th month
Engagement with the intervention
Internal
pilot
60% of participants classified as treatment completers by 9th
month
96% participants classified as treatment completers by 6th
month
Full trial Not specified 90.6% completed
Retention to primary end point
Internal
pilot
80% retention by 9th month 88% retention by 6th month
Full trial 80% retention 90% retention
Treatment completers were specified a prior as completion of the first 4/10 therapy chapters
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in a specialist centre for the disorder where there
are already established treatments available. As evi-
denced in ORBIT, the two research centres were
specialist Tourette syndrome centres and only re-
ferred 13 patients (2.9% of referrals) into the trial.
4) Patient and public involvement: ORBIT recruitment
documents were co-developed with an involvement
group of children and young people with Tourette
syndrome or chronic tic disorders and their parent/
carers. The group informed on use of language,
length of documents and layout, including incorpor-
ating different versions of information sheets for
younger and older children. Additionally, the re-
search team produced monthly short ‘spotlight on
the researcher’ video-blogs and animated recruit-
ment videos, which were hosted on Tourettes Ac-
tion’s webpage. These videos engaged families with
the research and resulted in spikes in self-referrals
after each post.
5) Regular monitoring and communication: The trial
manager tracked recruitment from each site and
produced monthly newsletters to PICs identifying
‘star recruiters’, promoting both the concept of
collaborative efforts to a shared goal as well as
inter-site competition. Each PIC had regular fort-
nightly communication with the Trial Manager to
promote engagement, build rapport and problem
solve specific issues where necessary.
6) Reimbursement and early exclusion: As participants
were required to travel across England for a
baseline assessment at one of the two research
centres, their travel costs were reimbursed by the
study team. The initial telephone screen prior to
this appointment enabled researchers to exclude
prospective participants who clearly did not meet
inclusion criteria to save patient and research time.
Potential reasons for retaining to target
We believe the following factors were critical to out-
come measure completion:
1) Online outcome measures: Automated reminders
sent via the database directly to the participant.
Additionally, these online outcome measures
allowed participants to directly enter their data into
the database and streamlined researcher time.
2) Tokens of appreciation: Participants were given £20
for completion of the outcome measures at each
time point. Khadjesari et al. [35] note that tokens of
appreciation of sufficient monetary value may also
promote completion of online measures; however,
ethics committees may be mindful of potential
financial coercion. This amount may arguably not
be seen as large enough to warrant coercion but
sufficient to keep participant interest.
3) Building a rapport: ORBIT researchers often
dedicated additional time in their online interviews
to listen to the family struggles and successes,
although they were careful not to offer advice
outside the constraint of the trial. Where required,
the researcher would send a standard approved
template letter to the child’s general practitioner
Fig. 2 ORBIT process for obtaining follow-up measures. The online and researcher based measures were completed as a simultaneous process.
Researchers checked several times a week to check meausure completion
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(GP) or school to signpost the potential need for
assessment or further support. Where possible, the
same researcher conducted baseline and all follow-
up assessments, which also promoted consistency
on measures that were subjectively rated by the re-
searcher. The researcher also recorded important
individual factors for each family (i.e. name of pet
or preferred hobby). It should be noted, this perso-
nalised information was stored against their an-
onymous participant ID, separate from their name,
address and date of birth, in a secure, password-
protected file, accessible only by the research team.
Where researchers failed to make contact the
ORBIT therapist was sometimes asked to contact
with the families if they had established a particu-
larly strong rapport during treatment.
4) Flexibility: ORBIT researchers conducted follow-up
interviews outside of normal working hours (such
as evenings and weekends) to provide flexibility, en-
suring that participation in the trial did not impact
on the families school/work commitments. Al-
though time of appointment was not recorded, our
researchers estimate from reviewing available infor-
mation in their diaries, that approximately 90% of
appointments took place outside a typical school
day, during the evening or weekend. Additionally,
where families were unable, felt uncomfortable or
experienced significant challenges using video-
conferencing, telephone meetings were offered as
an alternative to improve participant experience.
5) Regular monitoring and communication: The trial
manager and researchers monitored retention rates
on a monthly basis. The team discussed retention
strategies and problem-solving.
Characteristics of the ORBIT interventions
In the ORBIT trial, both arms received a therapist
guided, online intervention for tics. One received a be-
havioural intervention based on exposure and response
prevention principles trialled in Sweden (‘BIP TIC’) [36],
and the other received psychoeducation developed by
the ORBIT study team based on the intervention devel-
oped by Piacentini et al. [37]. Engagement with the
ORBIT intervention exceeded expectations. The internal
pilot specified that 60% of participants had to have com-
pleted treatment, the actual number completing was
96%. Overall, treatment completion for the trial was
90.6%. We consider the following factors to have been
instrumental in influencing this positive uptake:
1) Poor current provision: As discussed in recruitment,
access to evidence-based behavioural therapies in
current care for this population was poor.
2) Active control: Both groups received an active
treatment that was likely to be more than they
would be offered in standard care in most centres.
Indeed, even in a specialist tic treatment centre,
some young people may be offered psychoeducation
(ORBIT active control) rather than behavioural
therapy if that was felt to meet the needs of the
young person best. At this current time, blinding
codes have not been broken thus we are unable to
comment on differences between arms; however,
with 90% completion rate, it is unlikely that there
would be a significant difference in engagement.
3) Remotely delivered: The content of the intervention
was delivered remotely enabling families to log-in
and complete the therapy at a time and place most
convenient to them. Although the therapist would
only respond or comment during standard working
hours, usually, this did not stop families in continu-
ing to progress.
4) Parent/carer support: Carers were actively engaged
with the intervention to enable them to act as a
‘supporter’ for their child’s treatment. The
supporters were provided with their own chapters
which gave information as to how to support the
child and the supporter played a key role in setting
goals and rewards as part of the intervention. The
therapists noted that typically the level of supporter
involvement was an influential factor in predicting
the child’s engagement, particularly for younger
children.
5) Therapist support: In ORBIT the main therapeutic
content was delivered via the online platform. As
such, the therapist’s role was to promote adherence
and motivation to the treatments, alongside setting
goals and reviewing goal attainment. Although the
therapist communications were primarily through
the online platform (telephone contact was
arranged, if requested), participants were
introduced to their therapist during the face-to-face
baseline appointment where possible. This was done
to promote treatment credibility and encourage a
rapport with the therapist. Similar to the re-
searchers, where possible, the family were in con-
tact with one therapist who remembered individual
information such as interests of the child, to build
rapport. Instances where the therapist went on
leave, this information was shared with the covering
therapist so that they could continue the established
relationship.
6) Research-supported infrastructure: Conducting
research in under-funded child mental health ser-
vices where there is inadequate infrastructure to
support additional research tasks is an additional
barrier. In ORBIT, the therapist was provided,
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trained and closely supervised by the research team,
reducing impact on the referring clinicians’
workload.
ORBIT research staff
The HTA data indicated that staffing issues were a key
factor in requiring variations to contracts. ORBIT had
two dedicated full-time researchers, one based at each of
the two research centres.
Primarily, the researchers’ role was to assess eligibility,
enrol participants into the trial, conduct baseline and
follow-up assessments and report any adverse events to
the trial manager. We reflect on the following factors
that were important for ORBIT researchers:
1) Peer support: Although the two main researchers
were located at different sites, they shadowed each
other and provided peer-support which was aided
by the trial manager. Monthly conference calls be-
tween the sites provided set time for shared learn-
ing experiences. The trial manager conducted
weekly checks on each sites’ performance and of-
fered support, advice or encouragement where
needed. Additionally, ORBIT benefited from collab-
orating with the Swedish team at Karolinska Institu-
tet that developed a first version of the active
intervention tested in the ORBIT trial. This team
also co-developed the database for outcome mea-
sures. Having easy access to staff at the Karolinska
Institute for technical support and to aid trouble-
shooting was extremely important for the trial
delivery.
2) Flexibility: As discussed previously, the two
researchers provided appointments outside normal
hours, including evening and weekends. This
involved substantial ‘good will’ from the researchers
and without this flexibility it is unlikely that the
retention to follow-up would have been so high.
3) Continuity: Where possible the same researcher
undertook both baseline and follow-up assessments.
4) Early identification of training: Undertaking trials is
a complex procedure, with various standard
operating procedures and guidelines which must be
adhered too. Completing this training can take a
significant amount of time which may impact on
when a researcher is able to start actively enrolling
participants into the trial. Appropriate time should
be built in to grant proposals to allow for adequate
researcher identification and training.
5) Additional funding: The time taken to undertake
each outcome measure is not a simple sum of the
time taken to administer the measure. Additional
tasks such as following up on adverse events,
sending letters to GPs or schools, rebooking if
families did not attend appointments, data entry
and responding to queries all added a significant
burden to researcher time that was not costed for.
ORBIT was only able to stay on track due to
additional NIHR infrastructure support provided by
NIHR MindTech MedTech Co-operative in the
form of both staff time and funding. An additional
part-time researcher was bought in during the first
4 months of recruitment to facilitate screening
across both sites, the costs for this were not pro-
vided by the HTA trial grant but were provided by
the NIHR MindTech MedTech Co-operative. Add-
itionally, ad-hoc support was provided by a PhD
student.
A summary of the challenges and opportunities
learned via ORBIT is presented in Table 5.
Discussion
With the aim of updating and building upon the pivotal
STEPS [9] study and providing researchers and funders
with a resource to inform future trial design and deliv-
ery, we presented data on current recruitment and re-
tention rates in trials funded by the HTA, a large UK
funder. These HTA data demonstrated that less than
half of trials of psychological/behavioural interventions
between 2010 and 2020 delivered on key targets recruit-
ment and retention. Comparatively, ORBIT (a trial of a
remotely supported behavioural intervention) recruited
to time and target and achieved 90% follow-up. We con-
sider that the careful use of technology blended with
well trained and motivated staff were key in achieving
this and also in facilitating participant engagement with
the intervention.
The HTA data demonstrated that only 40% of trials
reviewed met their initial recruitment target, and issues
with recruitment were the single biggest factor (54%) for
not completing trials to time-and-target. Our findings
are comparable to the STEPS [9] study and a more re-
cent study of published HTA trials [13] who estimated
that approximately 30–50% of trials met their recruit-
ment target. Although it is not possible to make a direct
comparison on trial design/population with the STEPS
paper, it is interesting that over 10 years later, recruit-
ment still remains a significant barrier in successful trial
completion. Similarly, in line with previous studies, we
also found evidence of poor retention rates in trials of
psychological interventions [15]. Only 47% of the studies
achieved their specified follow-up rate even with exten-
sions, indicating that the majority of trials were poten-
tially under-powered. However, issues with follow-up
were less frequently cited for reasons for requesting
funding extensions. It should be noted that follow-up
data was not available for 17 of the 51 studies due to
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historical differences in HTA systems for record keeping,
as such it is possible that our findings may not accur-
ately represent the full picture.
Although limitations in HTA standard reporting pre-
cluded comparisons of intervention engagement between
trials, we considered it was important to reflect on the
intervention engagement in ORBIT as this was likely a
factor in subsequent retention. Non-adherence to the
intervention is a common problem in RCTs, with inter-
vention non-adherence ranging from 2 to 78% in drug
and psychological/behavioural intervention trials, with a
median of 38% non-adherence [38]. Furthermore, a re-
cent systematic review revealed that treatment adher-
ence is particularly overlooked in internet-based trials.
For example, Koneska et al. [22] found that although
90% of trials of an internet-delivered intervention col-
lected usage data, only 39% investigated the level of
intervention use and only 21% used statistical methods
to account for this differential usage in the analysis.
Without presenting information on intervention comple-
tion, it is difficult to know if the intervention itself is not
effective and estimate intervention specific effects on re-
tention [22]. Furthermore, although the trial methodo-
logical processes were undoubtedly important in
promoting recruitment and engagement, the success of
the trial was also based on offering an attractive inter-
vention which was, otherwise, unavailable thereby ad-
dressing an unmet need. The acceptability of the ORBIT
intervention is currently being explored via a process
evaluation, including a qualitative component of partici-
pants’ opinion and experiences [39].
Due to restrictions on the granularity of detail of the
HTA, it is not possible to know the specific characteris-
tics or reasons why many studies did not meet their ini-
tial targets. For example, it would have been interesting
to have been able to examine differences across partici-
pant conditions/characteristics, or issues that may have
arisen with study set-up, or how many studies offered
monetary incentives to participants. It was also not pos-
sible to distinguish between performances of online or
non-online delivered trials from the HTA data set, al-
though it is likely that different types of trial delivery
have their own set of challenges. Indeed, some previous
studies indicate that online trials are susceptible to spe-
cific challenges such as potential breaches to confidenti-
ality through online communication [40] as well as lack
of personalisation and difficulties with rapport building
with participants [41]. Furthermore, it is likely that con-
ducting trials with any online element may be particu-
larly problematic in elderly or very deprived populations,
Table 5 Summary of challenges and opportunities from the ORBIT trial
Challenge Solutions and opportunities
Recruitment National (or geographically large scale) recruitment
Self-referrals (reduce reliance on clinical referrals)
Intervention meets an unmet need
Patient and public involvement on design and patient facing documents
Regular monitoring and communication with recruiting sites
Reimbursement for participant travel and early exclusion prior to attending a face-to-face appointment
Retention Online outcome measures
Participant tokens of appreciation
Building participant rapport and patient and public involvement in study design
Flexibility in completing follow-up interviews outside normal office hours
Regular monitoring and communication with trial staff





Research-supported infrastructure (research teams provide require staff/training)
Research staff Peer support
Flexibility in working pattern
Continuity
Early identification of training
Additional funding
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with poor internet access and/or lack of privacy, and
thus, we are not advocating online delivery as a blanket
approach. For children and young people, delivering on-
line interventions in school/ colleges setting may miti-
gate some of these access limitations associated with the
home. However, utilising the ORBIT trial as an example,
we illustrate how online delivery of interventions and
outcome measures may help increase the geographical
reach for recruitment by avoiding costly and time-
consuming visits to clinic for both participants and re-
searchers/therapists. Online interventions may also aid
intervention engagement for some, by allowing flexibility
to complete treatments from home at evenings or week-
ends. Greater standardisation of procedures using online
delivery also has the potential to reduce cross-
contamination, which is a particular risk in standard
face-to-face trials where therapists deliver multiple inter-
ventions. Furthermore, online delivery of interventions
may be more cost-effective, reducing the need for
highly-skilled therapists. Finally, completing outcome
measures online directly into trial databases with auto-
mated reminders for completion is likely to reduce bur-
den for researchers, data-entry time and errors and may
promote greater completion of measures.
Although on the surface it may seem tempting to rely
solely on online methods for delivery of both interven-
tions and outcome measures, we also highlight the key
role that research staff play in promoting good recruit-
ment and retention rates. It should also be noted that
the ORBIT intervention integrated remote, therapist
support. It is notable that issues with staffing were a re-
current reason for requests for variations to contracts in
the HTA data. Though these reasons are not specified in
more detail, continuity in research staff in ORBIT was
identified as an important factor in promoting retention,
particularly in building an ongoing rapport with partici-
pants. Previous studies have also indicated the import-
ance of good staff communication [20] and that high
staff turnover is associated with lower participant adher-
ence [42], but also in a cyclical manner that difficulties
in recruitment and retention of participants can reduce
staff moral [19], which may in turn lead to staff turn-
over.
ORBIT researchers also worked highly flexible work-
patterns which included out-of-hours appointments to
gather face-to-face outcome measures, to bolster the
flexibility of online delivery for families taking part. As
such, they encompassed the benefits of flexibility associ-
ated with online delivery but equally as important were
able to build a rapport with participants. It should be
noted that the flexible work-patterns may increase strain
on research staff and although online delivery may go
some way in reducing some of the demands associated
with outcome measure completion (i.e. reduce data entry
and automated reminders), greater investment is needed
to understand how we can best recruit and retain/sup-
port staff as well as participants. We also note that re-
search staff time should be appropriately costed, with
the time taken to complete outcome measures being
more than the sum total of minutes to deliver each item.
Additional time is needed for rapport building (i.e. con-
versation with families), non-attendance and repeated at-
tempts to make contact. Furthermore, as evidenced by
the HTA data, long-term staff leave (i.e. sickness or ma-
ternity) can represent a significant threat to trials and
there is benefit in having ‘bank researchers’ who are
trained in the trial procedures and with the necessary
permissions to provide immediate cover when required.
The demand for staff time can vary across the lifespan
of the trial—with particular pressures at various phases
(e.g. initial recruitment/ enrolment and at follow-ups be-
fore the first participants leave trial). Although research
staff costs typically represent a significant proportion of
research funds, it is important that this is adequately
costed to facilitate successful delivery. On reflection, we
consider the ORBIT trial was under costed and the
provision of additional staff was only possible with sup-
port from co-located NIHR infrastructure. This add-
itional support is unlikely to be available to most funded
trials. Although staff time is arguably one of the most
expensive aspects of grant bid, funding bodies need to
consider this cost balanced against the cost of partially-
powered studies that have been unable to recruit/retain
to target or that have required costed extensions to
contracts.
Our experience of conducting research in child and
adolescent mental health services in the UK indicates
that these services often do not have appropriate infra-
structure to support research delivery. We consider one
of the key strengths of ORBIT was that therapists were
identified, trained, closely supervised and employed by
the research team, reducing the strain on already over-
burdened healthcare systems. This was facilitated by the
online delivery and therapist-supported self-help design
of the intervention which allowed few therapists to sup-
port a large number of participants across a large geo-
graphical region. For example, ORBIT therapists
supported up to 30 patients at one time, whereas for cli-
nicians providing traditional face-to-face individual de-
livery of tic treatment this would likely be a much
smaller caseload. Although online interventions can also
be delivered without any therapist support, substantial
research evidence indicates that therapist supported in-
terventions promote better adherence than self-directed
[43], and we consider this blended approach of human
and online delivery to be a key factor in the engagement
with the intervention. As part of ORBIT, ongoing imple-
mentation work is investigating how this system may be
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best positioned if it were to be part of routine care. It
should be noted that all the research costs, such as a
suite of outcome measures, sophisticated analytical data-
bases, randomisation systems are unlikely to be required
if the intervention was delivered in routine care. Thus,
the short-term research costs should be balanced against
a longer-term societal benefit. Blending digitally deliv-
ered interventions has previously been reported as par-
ticularly advantageous for delivering treatment, offering
the opportunity to improve access to cost-effective treat-
ments that are efficacious in supporting behavioural
change [44]. Here we demonstrate that blending
technology-supported procedures (i.e. referrals, outcome
measure completion and the intervention) with research
staff to deliver trials is likely to be a promising avenue
for trial methodology.
Conclusion
Recruitment, retention/engagement and trial staff are
key factors for successful trial delivery and are likely to
be the biggest risk factors in trial completion. Utilising
an example of an online-delivered trial with human sup-
port (ORBIT) we demonstrate how a blended human/
online approach may be particularly advantageous in fa-
cilitating trial delivery, particularly in over-stretched and
under-resourced services or in hard to reach populations
who are comfortable in using technology (such as youth
populations). Potential benefits include flexibility in the
timing and location of delivery of interventions and
measures, partially or fully automated data collection
and ability to recruit over a large geographical area
whilst maintaining a rapport delivered by human sup-
port. We also advocate that trials are adequately costed
in the initial bid development phases to provide the ne-
cessary infrastructure and staff to support delivery. Fur-
ther research is required to improve trial delivery and
reduce waste of human and economic resources.
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